Psychedelics Venture Capital Firm Appoints Two New Advisory Board Members

Iter Investments, a venture capital firm that provides capital to businesses involved in the growing psychedelic industry, recently appointed pharmaceutical industry veteran John M.H. Gregg (pictured, left) and medical research council Ph.D. fellow Rayyan Zafar (pictured, top) to its advisory board.

“John’s deep expertise in leading biotech companies in central nervous system (CNS) drug development and Rayyan’s background in designing and conducting clinical trials for psychedelic medicines will prove to be key assets to Iter Investment’s future success and forging the path forward for the psychedelic industry,” says Dustin Robinson, co-founder and managing principal of Iter Investments. “We are excited to welcome John and Rayyan to the Iter Investments team.”

Gregg brings vast experience in forming and guiding infectious disease companies. His expertise involves clinical development and commercialization of psychiatric drugs, anti-infectives, immunology therapeutics and oncology products, including Solosec (Secnidazole), which received FDA approval in September 2017. He has also served as CEO of specialty infectious disease start-ups such as his current company, BalinBac Therapeutics, focused on developing direct antivirals for COVID-19. He holds a B.A. from the University of Chicago and an M.B.A. from New York University and is a member of the American Society of Microbiology, the American Chemical Society, the American Society of Hematology and the American Association of Pharmaceutical Scientists.

Zafar is a medical research council Ph.D. fellow at the Centre for Psychedelic Research and Neuropsychopharmacology at Imperial College London. He works alongside Professor David Nutt and his team in clinical and brain imaging studies to assess the efficacy of psychedelics and mechanisms of action of these medicines across addiction and psychiatric disorders. He is also an honorary research assistant at DrugScience, the leading international independent committee on the science of drugs, where he publishes policy and peer-reviewed reports on medical cannabis and its use in clinical populations. He has also worked on scientific advisory boards for companies developing drugs in the medical psychedelic and cannabis space. 

“Iter Investments is committed to building a multi-disciplinary, world-class team to both diligence our investments and add value to our portfolio companies,” says Robert Velarde, co-founder of Iter Investments. “Combining John and Rayyan’s background and expertise with our current team’s knowledge and skills allows Iter Investments to properly navigate this emerging industry and create value for our portfolio companies and the psychedelic industry at large.”

Iter Investment’s advisory board assists the company with opportunity identification, diligence and portfolio management. 

You May Also Like
This CEO Blends His High-Velocity Business with Life in the Fast Lane

Bitlux CEO Kyle Patel has always loved all “things that went fast”—and now they’re as much a part of work as they are recreational.

Read More
Cameron Mitchell’s journey as a restaurateur and CEO has always been rooted in people-first values

At the heart of Mitchell’s success is his deeply held belief that happy associates lead to happy guests—and ultimately, successful business outcomes.

Read More
New Report: Florida’s New Business Formations Among Highest in U.S.

The report attributes this partly to an increase in the necessity to innovate during challenging times.

Read More
IFA World Franchise Show 2025 Comes to Miami Beach Convention Center

Florida was recently named one of the top states for franchise growth in 2025.

Read More
Other Posts
Planes, Rockets, Yachts and More: South Florida is the Global Servicing Hub For All

Hollywood-based Heico Corp. co-CEO Victor Mendelson says, “If it flies, we’re on it… we make the guts inside.”

Read More
High property taxes among the unpleasant costly surprises greeting wealthy transplants to Florida

Despite that fact, year-round sunshine, a lively social scene and the Florida lifestyle supersede the lack of cost savings.

Read More
Miami Continues to lead the World When it Comes to Cruising

PortMiami welcomes 8.2 million passengers annually and leads the way in sustainability with the largest shore-power system in the world.

Read More
New Survey: 45% of Americans Say Tariffs are Affecting Their Travel Plans

Despite the WalletHub report’s findings, 20% of people say they’d take on debt before skipping a vacation.

Read More